Foghorn Therapeutics Inc. (FHTX) Scorecard
- 2026-Q2: Total return Lose; Revenue growth Win; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Win; EPS growth Lose.
- 2025-Q4: Total return Win; Revenue growth Win; EPS growth Lose.
- 2025-Q3: Total return Lose; Revenue growth Lose; EPS growth Lose.
26/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 4 wins, 8 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q21/3 |
LoseFHTX / S&P 2.09% / 15.20% |
WinFHTX / S&P 51.98% / 15.00% |
LoseFHTX / S&P -17.65% / 50.40% |
| 2026-Q11/3 |
LoseFHTX / S&P -11.48% / -4.33% |
WinFHTX / S&P 20.08% / 11.30% |
LoseFHTX / S&P -14.71% / 27.70% |
| 2025-Q42/3 |
WinFHTX / S&P 10.43% / 2.65% |
WinFHTX / S&P 36.75% / 9.00% |
LoseFHTX / S&P -29.09% / 13.40% |
| 2025-Q30/3 |
LoseFHTX / S&P 4.04% / 8.12% |
LoseFHTX / S&P -3.91% / 4.61% |
LoseFHTX / S&P -41.15% / 13.45% |
| 2025-Q21/3 |
WinFHTX / S&P 28.77% / 10.94% |
LoseFHTX / S&P -31.30% / 4.83% |
LoseFHTX / S&P -38.97% / 10.63% |
| 2025-Q10/3 |
LoseFHTX / S&P -22.67% / -4.27% |
LoseFHTX / S&P -30.66% / 4.98% |
LoseFHTX / S&P -38.18% / 10.57% |
| 2024-Q40/3 |
LoseFHTX / S&P -49.30% / 2.41% |
LoseFHTX / S&P -33.83% / 5.25% |
LoseFHTX / S&P -29.49% / 6.15% |
| 2024-Q31/3 |
WinFHTX / S&P 61.91% / 5.89% |
LoseFHTX / S&P -21.66% / 5.89% |
LoseFHTX / S&P -21.95% / 6.11% |
| 2024-Q21/3 |
LoseFHTX / S&P -14.31% / 4.28% |
WinFHTX / S&P 61.95% / 5.38% |
LoseFHTX / S&P -28.83% / 5.12% |
| 2024-Q11/3 |
LoseFHTX / S&P 4.03% / 10.56% |
WinFHTX / S&P 64.41% / 5.71% |
LoseFHTX / S&P -18.52% / 5.59% |
| 2023-Q42/3 |
WinFHTX / S&P 29.00% / 11.69% |
WinFHTX / S&P 77.63% / 6.81% |
LoseFHTX / S&P -10.69% / 7.78% |
| 2023-Q31/3 |
LoseFHTX / S&P -28.98% / -3.27% |
WinFHTX / S&P 106.70% / 7.52% |
LoseFHTX / S&P -8.89% / -5.03% |
| 2023-Q23/3 |
WinFHTX / S&P 13.55% / 8.74% |
WinFHTX / S&P 137.08% / 9.50% |
WinFHTX / S&P -1.79% / -8.57% |
| 2023-Q12/3 |
LoseFHTX / S&P -2.82% / 7.50% |
WinFHTX / S&P 316.25% / 10.77% |
WinFHTX / S&P -2.17% / -15.69% |
| 2022-Q42/3 |
LoseFHTX / S&P -25.64% / 7.56% |
WinFHTX / S&P 1357.77% / 11.88% |
WinFHTX / S&P -4.03% / -17.99% |
| 2022-Q31/3 |
LoseFHTX / S&P -36.91% / -4.88% |
WinFHTX / S&P 1738.62% / 13.47% |
LoseFHTX / S&P -573.68% / -1.41% |
| 2022-Q23/3 |
WinFHTX / S&P -10.70% / -16.10% |
WinFHTX / S&P 821.01% / 13.71% |
WinFHTX / S&P 51.63% / 11.04% |
| 2022-Q11/3 |
LoseFHTX / S&P -33.41% / -4.60% |
WinFHTX / S&P 591.76% / 15.97% |
LoseFHTX / S&P -32.85% / 42.23% |
| 2021-Q42/3 |
WinFHTX / S&P 64.18% / 11.03% |
WinFHTX / S&P 206.74% / 15.00% |
LoseFHTX / S&P FHTX unavailable / 96.40% |
| 2021-Q31/3 |
WinFHTX / S&P 30.55% / 0.58% |
LoseFHTX / S&P FHTX unavailable / 10.77% |
LoseFHTX / S&P FHTX unavailable / 69.42% |
| 2021-Q20/3 |
LoseFHTX / S&P -19.04% / 8.55% |
LoseFHTX / S&P FHTX unavailable / 6.58% |
LoseFHTX / S&P FHTX unavailable / 51.81% |
| 2021-Q10/3 |
LoseFHTX / S&P -34.98% / 6.17% |
LoseFHTX / S&P FHTX unavailable / -1.06% |
LoseFHTX / S&P FHTX unavailable / 7.39% |
| 2020-Q40/3 |
LoseFHTX / S&P FHTX unavailable / 12.15% |
LoseFHTX / S&P FHTX unavailable / -3.72% |
LoseFHTX / S&P FHTX unavailable / -33.42% |
| 2020-Q30/3 |
LoseFHTX / S&P FHTX unavailable / 8.93% |
LoseFHTX / S&P FHTX unavailable / -2.04% |
LoseFHTX / S&P FHTX unavailable / -27.10% |
| 2020-Q20/3 |
LoseFHTX / S&P FHTX unavailable / 20.54% |
LoseFHTX / S&P FHTX unavailable / -0.46% |
LoseFHTX / S&P FHTX unavailable / -27.11% |
| 2020-Q10/3 |
LoseFHTX / S&P FHTX unavailable / -19.60% |
LoseFHTX / S&P FHTX unavailable / 3.47% |
LoseFHTX / S&P FHTX unavailable / -14.75% |
| 2019-Q40/3 |
LoseFHTX / S&P FHTX unavailable / 9.07% |
LoseFHTX / S&P FHTX unavailable / 5.36% |
LoseFHTX / S&P FHTX unavailable / 2.99% |
| 2019-Q30/3 |
LoseFHTX / S&P FHTX unavailable / 1.70% |
LoseFHTX / S&P FHTX unavailable / 5.02% |
LoseFHTX / S&P FHTX unavailable / 0.21% |
| 2019-Q20/3 |
LoseFHTX / S&P FHTX unavailable / 4.30% |
LoseFHTX / S&P FHTX unavailable / 6.64% |
LoseFHTX / S&P FHTX unavailable / 8.65% |
| 2019-Q10/3 |
LoseFHTX / S&P FHTX unavailable / 13.65% |
LoseFHTX / S&P FHTX unavailable / 8.12% |
LoseFHTX / S&P FHTX unavailable / 14.29% |
| 2018-Q40/3 |
LoseFHTX / S&P FHTX unavailable / -13.52% |
LoseFHTX / S&P FHTX unavailable / 9.05% |
LoseFHTX / S&P FHTX unavailable / 18.23% |
| 2018-Q30/3 |
LoseFHTX / S&P FHTX unavailable / 7.71% |
LoseFHTX / S&P FHTX unavailable / 10.21% |
LoseFHTX / S&P FHTX unavailable / 19.06% |
| 2018-Q20/3 |
LoseFHTX / S&P FHTX unavailable / 3.43% |
LoseFHTX / S&P FHTX unavailable / 9.03% |
LoseFHTX / S&P FHTX unavailable / 14.46% |
| 2018-Q10/3 |
LoseFHTX / S&P FHTX unavailable / -0.76% |
LoseFHTX / S&P FHTX unavailable / 7.68% |
LoseFHTX / S&P FHTX unavailable / 12.46% |
| 2017-Q40/3 |
LoseFHTX / S&P FHTX unavailable / 6.64% |
LoseFHTX / S&P FHTX unavailable / 7.03% |
LoseFHTX / S&P FHTX unavailable / 13.82% |
| 2017-Q30/3 |
LoseFHTX / S&P FHTX unavailable / 4.48% |
LoseFHTX / S&P FHTX unavailable / 5.68% |
LoseFHTX / S&P FHTX unavailable / 17.57% |
| 2017-Q20/3 |
LoseFHTX / S&P FHTX unavailable / 3.09% |
LoseFHTX / S&P FHTX unavailable / 4.83% |
LoseFHTX / S&P FHTX unavailable / 17.74% |
| 2017-Q10/3 |
LoseFHTX / S&P FHTX unavailable / 6.07% |
LoseFHTX / S&P FHTX unavailable / 3.67% |
LoseFHTX / S&P FHTX unavailable / 13.32% |
| 2016-Q40/3 |
LoseFHTX / S&P FHTX unavailable / 3.82% |
LoseFHTX / S&P FHTX unavailable / 2.09% |
LoseFHTX / S&P FHTX unavailable / 7.05% |
| 2016-Q30/3 |
LoseFHTX / S&P FHTX unavailable / 3.85% |
LoseFHTX / S&P FHTX unavailable / 0.20% |
LoseFHTX / S&P FHTX unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | FHTX total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 22.92% | 20.78% |
| Annualized return | 22.92% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | FHTX total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -53.72% | 83.14% |
| Annualized return | -14.28% | 12.86% |
10Y · 2020-10-23 to 2026-08-27
| Metric | FHTX total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -65.67% | 319.30% |
| Annualized return | -10.14% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |